SEBI passed an ex-parte interim order dated Jan. 14, 2020 against FWCS and its present and past directors Dhiraj Gupta, Sumit Kumar, Hemanchal Singh, Ravindra Singh and Ashutosh Sharma.
The Board of Directors of Vivimed Labs Limited have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23, H1FY23 at its board meeting.
/PRNewswire/ The Triclosan market will register an incremental spend of about USD 83.07 Million, growing at a CAGR of 4.02% during the five-year forecast.